Envoy Medical (COCH) Net Equity Issued and Repurchased (2024 - 2026)
Envoy Medical's (COCH) quarterly Net Equity Issued and Repurchased came in at $30.0 million in Q1 2026, up 14184.29% quarter-over-quarter from $210000.0 in Q3 2025.
Powered by 
Analysis
Envoy Medical (COCH) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends
Envoy Medical has disclosed Net Equity Issued and Repurchased across 3 years of filings, most recently posting $30.0 million for Q1 2026.
- In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $30.0 million; the TTM figure through Jun 2026 stood at $30.2 million (changed N/A YoY), while the FY2025 annual figure was $414000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased came in at $30.0 million for Q1 2026 at Envoy Medical, up from $210000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $30.0 million in Q1 2026 to a low of $210000.0 in Q3 2025.
- Average Net Equity Issued and Repurchased over 3 years is $10.6 million, with a median of $1.7 million recorded in 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | Envoy Medical | 72.94 Mn | 53.26 Mn | -227,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 30.00 Mn |
| Sep 30, 2025 | 210,000.00 |
| Mar 31, 2024 | 1.68 Mn |